Eastern promises: Additive role of metabolic syndrome for thromboembolic risk stratification in Taiwanese atrial fibrillation patients.
作者信息
Dixit Sanjay, Kini Vinay
机构信息
Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
出版信息
Heart Rhythm. 2014 Mar;11(3):358-9. doi: 10.1016/j.hrthm.2013.12.001. Epub 2013 Dec 4.
Abstract
摘要
相似文献
1
Eastern promises: Additive role of metabolic syndrome for thromboembolic risk stratification in Taiwanese atrial fibrillation patients.东方的前景：代谢综合征在台湾心房颤动患者血栓栓塞风险分层中的附加作用
Heart Rhythm. 2014 Mar;11(3):358-9. doi: 10.1016/j.hrthm.2013.12.001. Epub 2013 Dec 4.
2
Additive effect of the metabolic syndrome score to the conventional CHADS₂ score for the thromboembolic risk stratification of patients with atrial fibrillation.代谢综合征评分对传统CHADS₂评分在房颤患者血栓栓塞风险分层中的附加作用。
Heart Rhythm. 2014 Mar;11(3):352-7. doi: 10.1016/j.hrthm.2013.11.014. Epub 2013 Nov 16.
3
[Risk stratification tools for evaluating thromboembolic risk in atrial fibrillation].用于评估心房颤动血栓栓塞风险的风险分层工具
Rev Med Suisse. 2011 Feb 2;7(280):313-6, 318-9.
4
Multimodality imaging for thromboembolic risk assessment in atrial fibrillation.多模态影像学在心房颤动血栓栓塞风险评估中的应用。
J Cardiovasc Med (Hagerstown). 2018 Dec;19(12):698-705. doi: 10.2459/JCM.0000000000000727.
5
[Atrial fibrillation--thromboembolism and prevention].[心房颤动——血栓栓塞与预防]
Ugeskr Laeger. 1991 Jul 22;153(30):2105-7.
6
Stratification of thromboembolic risk of atrial fibrillation by transthoracic echocardiography and transesophageal echocardiography: the relative role of left atrial appendage function, mitral valve disease, and spontaneous echocardiographic contrast.经胸超声心动图和经食管超声心动图对心房颤动血栓栓塞风险的分层：左心耳功能、二尖瓣疾病及自发超声造影的相对作用
Prog Cardiovasc Dis. 1996 Jul-Aug;39(1):57-68. doi: 10.1016/s0033-0620(96)80041-7.
7
[Thromboembolic risk in atrial fibrillation: new clinical perspectives].[心房颤动中的血栓栓塞风险：新的临床视角]
G Ital Cardiol (Rome). 2008 Oct;9(10 Suppl 1):22S-26S.
8
The Relationship Between Mitral Annular Calcification, Metabolic Syndrome and Thromboembolic Risk.二尖瓣环钙化、代谢综合征与血栓栓塞风险之间的关系
Braz J Cardiovasc Surg. 2019 Dec 1;34(5):535-541. doi: 10.21470/1678-9741-2019-0062.
9
Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators.心房颤动血栓栓塞的预测因素：II. 高危患者的超声心动图特征。心房颤动预防中风研究人员。
Ann Intern Med. 1992 Jan 1;116(1):6-12. doi: 10.7326/0003-4819-116-1-6.
10
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).心房颤动抗凝治疗患者血栓栓塞和出血事件的风险因素：前瞻性、多中心观察性预防血栓栓塞事件-心房颤动欧洲登记研究（PREFER in AF）。
BMJ Open. 2019 Mar 30;9(3):e022478. doi: 10.1136/bmjopen-2018-022478.
本文引用的文献
1
Additive effect of the metabolic syndrome score to the conventional CHADS₂ score for the thromboembolic risk stratification of patients with atrial fibrillation.代谢综合征评分对传统CHADS₂评分在房颤患者血栓栓塞风险分层中的附加作用。
Heart Rhythm. 2014 Mar;11(3):352-7. doi: 10.1016/j.hrthm.2013.11.014. Epub 2013 Nov 16.
2
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.CHA2DS2-VASc 评分可识别出那些房颤合并 CHADS2 评分为 1 分的患者，他们不太可能从口服抗凝治疗中获益。
Eur Heart J. 2013 Jan;34(3):170-6. doi: 10.1093/eurheartj/ehs314. Epub 2012 Sep 27.
3
Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study.CHA2DS2VASc风险评分对房颤患者中风和死亡的额外预测能力：丹麦饮食、癌症和健康前瞻性队列研究
Circ Cardiovasc Qual Outcomes. 2012 May;5(3):335-42. doi: 10.1161/CIRCOUTCOMES.111.964023. Epub 2012 Apr 24.
4
Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.日本老年非瓣膜性心房颤动患者服用华法林的临床转归：一项单中心观察性研究。
Thromb Res. 2012 Jul;130(1):21-6. doi: 10.1016/j.thromres.2011.11.005. Epub 2011 Dec 3.
5
Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation-- a nation wide database analysis.台湾地区非瓣膜性心房颤动患者缺血性脑卒中的风险因素和发生率——一项全国性数据库分析。
Atherosclerosis. 2011 Jul;217(1):292-5. doi: 10.1016/j.atherosclerosis.2011.03.033. Epub 2011 Apr 5.
6
Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.尽管进行了抗凝治疗，仍识别出有卒中风险的患者：在抗凝治疗的心房颤动队列中比较当代卒中风险分层方案。
Stroke. 2010 Dec;41(12):2731-8. doi: 10.1161/STROKEAHA.110.590257. Epub 2010 Oct 21.
7
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.采用新型基于风险因素的方法对房颤患者的卒中与血栓栓塞风险进行临床分层的研究：房颤的欧洲心脏调查。
Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584. Epub 2009 Sep 17.
8
Gender differences in smoking behaviors in an Asian population.亚洲人群吸烟行为中的性别差异。
J Womens Health (Larchmt). 2008 Jul-Aug;17(6):971-8. doi: 10.1089/jwh.2007.0621.
9
Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.选择房颤患者进行抗凝治疗：服用阿司匹林患者的卒中风险分层
Circulation. 2004 Oct 19;110(16):2287-92. doi: 10.1161/01.CIR.0000145172.55640.93. Epub 2004 Oct 11.
10
Prevention of stroke in patients with nonvalvular atrial fibrillation.非瓣膜性心房颤动患者的卒中预防
Neurology. 1998 Sep;51(3):674-81. doi: 10.1212/wnl.51.3.674.
Zotero 插件